Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2020 / N 4

Софизмы в современной доктрине рациональной терапии хронической боли в нижней части спины и пути их преодоления
И.Н. Самарцев, С.А. Живолупов

References

1. Ma K, Zhuang G, Wang L, Liu XG, Lu LJ, Yang XQ, Lu Y, Fu ZJ, Song T, Huang D, Liu H, Huang YQ, Peng BG, Liu YQ. The Chinese Association for the Study of Pain (CASP): Consensus on the assessment and management of chronic nonspecific low back pain. Pain Research & Management 2019 Aug;2019:8957847.
2. Borenstein D. Low back pain and lumbar spinal stenosis. In: Rheumatology. 2-vol. set. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. 2nd ed. London: Mosby; 2003: 583-613.
3. Melloh M, Röder C, Elfering A, Theis JC, Müller U, Staub LP, Aghayev E, Zweig T, Barz T, Kohlmann T, Wieser S, Jüni P, Zwahlen M. Differences across health care systems in outcome and cost-utility of surgical and conservative treatment of chronic low back pain: a study protocol. BMC Musculoskeletal Disorders 2008 Jun;9:81.
4. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Archives of Internal Medicine 2009 Feb;169(3):251-8.
5. Meucci R, Fassa AG, Paniz VM, Silva MC, Wegman DH. Increase of chronic low back pain prevalence in a medium-sized city of southern Brazil. BMC Musculoskeletal Disorders 2013 May;14:155.
6. Meucci RD, Fassa AG, Faria NMX. Prevalence of chronic low back pain: systematic review. Revista de Saúde Pública 2015;49:74.
7. Alkherayf F, Agbi C. Cigarette smoking and chronic low back pain in the adult population. Clinical and Investigative Medicine 2009 Oct;32(5):E360-7.
8. Waxman R, Tennant A, Helliwell P. A prospective follow-up study of low back pain in the community. Spine 2000 Aug;25(16):2085-90.
9. Vorobyova OV. Chronic back pain: from pathogenetic concepts to therapeutic strategies. Medical Council 2017;17:36-42 (In Russian).
10. Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede RD. Neuropathic low back pain in clinical practice. European Journal of Pain (London, England) 2016;20:861-73.
11. Balagué F, Mannion AF, Pellisé F, Cedraschi C. Non-specific low back pain. The Lancet 2012 Feb;379(9814):482-91.
12. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Medicine (Malden, Mass.) 2011 Feb;12(2):224-33.
13. Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. The Journal of Bone and Joint Surgery. British Volume 2005 Jan;87(1):62-7.
14. van Kleef M, Vanelderen P, Cohen S, Lataster A, Van Zundert J, Mekhail N. Pain originating from the lumbar facet joints. Pain Practice 2010 Sep-Oct;10(5):459-69.
15. Souza TA. Differential diagnosis and management for the chiropractor: protocols and algorithms. 2nd ed. Gaithersburg, MD: Aspen Publishers; 2001: 34.
16. International Association for the Study of Pain. IASP Council adopts Task Force recommendation for third mechanistic descriptor of pain. Nov 14, 2017. Available from: https://www.iasp-pain.org/PublicationsNews/NewsDetail.aspx? ItemNumber=6862 Accessed 2020 Dec 22.
17. Bakker EWP, Verhagen AP, van Trijffel E, Lucas C, Koes BW. Spinal mechanical load as a risk factor for low back pain: a systematic review of prospective cohort studies. Spine 2009 Apr;34(8):E281-93.
18. Zhivolupov SA, Samartsev IN, Syroyezhkin FA. Contemporary concept of neuroplasticity: theoretical aspects and practical significance. SS Korsakov Journal of Neurology and Psychiatry 2013;113(10):102-8 (In Russian).
19. Reichling D, Levine J. Critical role of nociceptor plasticity in chronic pain. Trends in Neurosciences 2009 Dec;32(12):611-8.
20. Woolf C, Salter M. Neuronal plasticity: increasing the gain in pain. Science (New York, N.Y.) 2000 Jun;288(5472):1765-9.
21. Ji R, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 2018 Aug;129(2):343-66.
22. Yaksh T, Dirig D, Conway C, Svensson C, Luo D, Isakson P. The acute antihyperalgesic action of non-steroidal, anti-inflammatory drugs and release of spinal PGE2 is mediated by the inhibition of constitutive spinal cyclo-oxygenase-2 (COX-2) but not COX-1. The Journal of Neuroscience 2001 Aug;21(16):5847-53.
23. Samad T, Moore K, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre J, Woolf C. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001 Mar;410(6827):471-5.
24. Beiche F, Klein T, Nüsing R, Neuhuber W, Goppelt-Struebe M. Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. Journal of Neuroimmunology 1998 Aug;89(1-2):26-34.
25. Wong J, Côté P, Ameis A, Varatharajan S, Varatharajan T, Shearer HM, Brison RJ, Sutton D, Randhawa K, Yu H, Southerst D, Goldgrub R, Mior S, Stupar M, Carroll LJ, Taylor-Vaisey A. Are non-steroidal anti-inflammatory drugs effective for the management of neck pain and associated disorders, whiplash-associated disorders, or non-specific low back pain? A systematic review of systematic reviews by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. European Spine Journal 2016 Jan;25(1):34-61.
26. Roelofs PDDM, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. The Cochrane Database of Systematic Reviews 2008 Jan 23;(1):CD000396.
27. Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. Journal of Pain Research 2012;5:579-90.
28. Birbara CA, Puopolo АD, Munoz DR, Sheldon EA, Mangione A, Bohidar NR, Geba GP; Etoricoxib Protocol 042 Study Group. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo-controlled, 3-month trial. The Journal of Pain 2003 Aug;4(6):307-15.
29. Pallay RM, Seger W, Adler JL, Ettlinger RE, Quaidoo EA, Lipetz R, O’Brien K, Mucciola L, Skalky CS, Petruschke RA, Bohidar NR, Geba GP. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scandinavian Journal of Rheumatology 2004;33(4):257-66.
30. Zerbini C, Ozturk ZE, Grifka J, Maini M, Nilganuwong S, Morales R, Hupli M, Shivaprakash M, Giezek H; Etoricoxib CLBP Study Group. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Current Medical Research and Opinion 2005 Dec;21(12):2037-49.
31. Malanga G, Reiter R, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opinion on Pharmacotherapy 2008 Aug;9(12):2209-15.
32. Walker AK, Kavelaars A, Heijnen CJ, Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacological Reviews 2013 Dec;11(1):80-101.
33. Schnitzer TJ, Ferraro A, Hunsche E, Kong SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. Journal of Pain and Symptom Management 2004 Jul;28(1):72-95.
34. Danilov AB, Zharkova TR, Akhmetdzhanova LT. Analgesic properties of alflutop in treatment of chronic back pain. Consilium Medicum. Neurology and Rheumatology 2010;2:26-9 (In Russian).
35. Levin OS, Olyunin DYu, Golubeva LV. Efficacy of alflutop in chronic vertebrogenic lumboishialgia: double-blind placebo-controlled study data. Rheumatology Science and Practice 2004;42(4):80-4 (In Russian).
36. Zhivolupov SA, Litvinenko IV, Samartsev IN, Rashidov NA, Kravchuk AYu, Barinov AN. Drug therapy of chronic musculoskeletal pain syndromes: concept of adjuvant analgesics and prospect of its implementation. Neurology, Neuropsychiatry, Psychosomatics 2020;12(1):105-11 (In Russian).
37. Kamper S, Apeldoorn A, Chiarotto A. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. The Cochrane Database of Systematic Reviews 2014 Sep 2;(9):Cd000963.
38. Wang H, Schiltenwolf M, Buchner M. The role of TNF-alpha in patients with chronic low back pain: a prospective, comparative longitudinal study. The Clinical Journal of Pain 2008 Mar-Apr;24(3):273-8.
39. de Queiroz BZ, Pereira DS, Lopes RA, Felício DC, Silva JP, de Britto Rosa NM, Dias JMD, Dias RC, Lustosa LP, Pereira LSM. Association between the plasma levels of mediators of inflammation with pain and disability in the elderly with acute low back pain: data from the back complaints in the elders (BACE) – Brazil study. Spine 2016 Feb;41(3):197-203.
40. Gebhardt K, Brenner H, Stürmer T, Raum E, Richter W, Schiltenwolf M, Buchner M. The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain – a 6 months prospective longitudinal study. European Journal of Pain (London, England) 2006 Nov;10(8):711-9.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]